NCT03531996View on ClinicalTrials.gov

The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis

CompletedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

April 19, 2018

Primary Completion Date

September 16, 2020

Study Completion Date

September 16, 2020

Conditions
Autoimmune Pulmonary Alveolar Proteinosis
Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT03531996 - The Longitudinal Evaluation of Autoimmune Pulmonary Alveolar Proteinosis | Biotech Hunter | Biotech Hunter